Ensuring Fairness in Prescription Drug Prices
13th Nov 2006, 06:45 GMT
The Nov. 2 editorial "An Election on Drugs" overlooked one salient fact. Most of the money spent on developing new drugs comes from public funds via the National Institutes of Health and universities. In fact, according to an analysis by health services professor Alan Sager, the big drug companies spent only 11 percent of their budget on research and development in 1999. This compares with 16 percent profit.
Ensuring Fairness in Prescription Drug Prices related news:
- Bush Administration says it opposes Democrats' plan to allow Government to negotiate Medicare drug prices — News-Medical News Feed
- Administration Opposes Democrats Plan for Negotiating Medicare Drug Prices — NYT > Washington
- Editorial: Lowering Medicare Drug Prices — NYT > Opinion
- HHS Chief Opposes Negotiation of Medicare Drug Prices — washingtonpost.com - A Section
- A pharmacist dispences Kaletra, an AIDS drug. Drug prices have ... — Health Photos on Yahoo! News Photos
- Déjà vu for Medicare prescription drug plan — The Daily News: Opinion
- Medicare drug coverage: the vital facts — Daily Star Front Page
- Drug prices for needy on the rise — Mail & Guardian Online
- Senior citizens to choose their prescription drug plan — The Earth Times Online Newspaper - Health News
- Seniors Struggle over Medicare Drug Gap Coverage — NPR Topics: News